These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 27629286)

  • 1. Glucagon in artificial pancreas systems: Potential benefits and safety profile of future chronic use.
    Taleb N; Haidar A; Messier V; Gingras V; Legault L; Rabasa-Lhoret R
    Diabetes Obes Metab; 2017 Jan; 19(1):13-23. PubMed ID: 27629286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial.
    Haidar A; Legault L; Messier V; Mitre TM; Leroux C; Rabasa-Lhoret R
    Lancet Diabetes Endocrinol; 2015 Jan; 3(1):17-26. PubMed ID: 25434967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial.
    El-Khatib FH; Balliro C; Hillard MA; Magyar KL; Ekhlaspour L; Sinha M; Mondesir D; Esmaeili A; Hartigan C; Thompson MJ; Malkani S; Lock JP; Harlan DM; Clinton P; Frank E; Wilson DM; DeSalvo D; Norlander L; Ly T; Buckingham BA; Diner J; Dezube M; Young LA; Goley A; Kirkman MS; Buse JB; Zheng H; Selagamsetty RR; Damiano ER; Russell SJ
    Lancet; 2017 Jan; 389(10067):369-380. PubMed ID: 28007348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial of a dual-hormone artificial pancreas with dosing adjustment during exercise compared with no adjustment and sensor-augmented pump therapy.
    Jacobs PG; El Youssef J; Reddy R; Resalat N; Branigan D; Condon J; Preiser N; Ramsey K; Jones M; Edwards C; Kuehl K; Leitschuh J; Rajhbeharrysingh U; Castle JR
    Diabetes Obes Metab; 2016 Nov; 18(11):1110-1119. PubMed ID: 27333970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual-hormone artificial pancreas: benefits and limitations compared with single-hormone systems.
    Peters TM; Haidar A
    Diabet Med; 2018 Apr; 35(4):450-459. PubMed ID: 29337384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between Optimum Mini-doses of Glucagon and Insulin Levels when Treating Mild Hypoglycaemia in Patients with Type 1 Diabetes - A Simulation Study.
    Ranjan A; Wendt SL; Schmidt S; Madsbad S; Holst JJ; Madsen H; Knudsen CB; Jørgensen JB; Nørgaard K
    Basic Clin Pharmacol Toxicol; 2018 Mar; 122(3):322-330. PubMed ID: 28922582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of artificial pancreas technologies with an emphasis on bi-hormonal therapy.
    Bakhtiani PA; Zhao LM; El Youssef J; Castle JR; Ward WK
    Diabetes Obes Metab; 2013 Dec; 15(12):1065-70. PubMed ID: 23602044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic Model Predictive Control of Bihormonal Artificial Pancreas System Based on Switching Control and Dynamic R-parameter.
    Tang F; Wang Y
    J Diabetes Sci Technol; 2017 Nov; 11(6):1112-1123. PubMed ID: 28728434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomised controlled trial.
    Haidar A; Legault L; Matteau-Pelletier L; Messier V; Dallaire M; Ladouceur M; Rabasa-Lhoret R
    Lancet Diabetes Endocrinol; 2015 Aug; 3(8):595-604. PubMed ID: 26066705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes: Artificial pancreas--first head-to-head comparison of dual-hormone and single-hormone systems.
    Holmes D
    Nat Rev Endocrinol; 2015 Feb; 11(2):63. PubMed ID: 25511314
    [No Abstract]   [Full Text] [Related]  

  • 11. An artificial pancreas for automated blood glucose control in patients with Type 1 diabetes.
    Schmidt S; Boiroux D; Ranjan A; Jørgensen JB; Madsen H; Nørgaard K
    Ther Deliv; 2015; 6(5):609-19. PubMed ID: 26001176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single- and Dual-Hormone Artificial Pancreas for Overnight Glucose Control in Type 1 Diabetes.
    Haidar A; Rabasa-Lhoret R; Legault L; Lovblom LE; Rakheja R; Messier V; D'Aoust É; Falappa CM; Justice T; Orszag A; Tschirhart H; Dallaire M; Ladouceur M; Perkins BA
    J Clin Endocrinol Metab; 2016 Jan; 101(1):214-23. PubMed ID: 26523526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low doses of dasiglucagon consistently increase plasma glucose levels from hypoglycaemia and euglycaemia in people with type 1 diabetes mellitus.
    Hövelmann U; Olsen MB; Mouritzen U; Lamers D; Kronshage B; Heise T
    Diabetes Obes Metab; 2019 Mar; 21(3):601-610. PubMed ID: 30350477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual-hormone artificial pancreas for management of type 1 diabetes: Recent progress and future directions.
    Infante M; Baidal DA; Rickels MR; Fabbri A; Skyler JS; Alejandro R; Ricordi C
    Artif Organs; 2021 Sep; 45(9):968-986. PubMed ID: 34263961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance and safety of an integrated bihormonal artificial pancreas for fully automated glucose control at home.
    Blauw H; van Bon AC; Koops R; DeVries JH;
    Diabetes Obes Metab; 2016 Jul; 18(7):671-7. PubMed ID: 26996542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of Commercially Available Glucagon Formulation for Dual-Hormone Artificial Pancreas Clinical Use.
    Taleb N; Coriati A; Khazzaka C; Bayonne J; Messier V; Rabasa-Lhoret R
    Diabetes Technol Ther; 2017 Oct; 19(10):589-594. PubMed ID: 28846447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of single-hormone and dual-hormone artificial pancreas during continuous and interval exercise in adult patients with type 1 diabetes: randomised controlled crossover trial.
    Taleb N; Emami A; Suppere C; Messier V; Legault L; Ladouceur M; Chiasson JL; Haidar A; Rabasa-Lhoret R
    Diabetologia; 2016 Dec; 59(12):2561-2571. PubMed ID: 27704167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Glucagon in Automated Insulin Delivery.
    Wilson LM; Jacobs PG; Castle JR
    Endocrinol Metab Clin North Am; 2020 Mar; 49(1):179-202. PubMed ID: 31980117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of subcutaneous, low-dose glucagon on insulin-induced mild hypoglycaemia in patients with insulin pump treated type 1 diabetes.
    Ranjan A; Schmidt S; Madsbad S; Holst JJ; Nørgaard K
    Diabetes Obes Metab; 2016 Apr; 18(4):410-8. PubMed ID: 26743775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The bionic pancreas: novel perspectives on insulin replacement therapies.
    Denecke C
    Transplantation; 2015 Feb; 99(2):268-9. PubMed ID: 25651115
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.